Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
favipiravir (2 trials)
remdesivir (Veklury) (1 trial)
COVID-19 convalescent plasma (1 trial)
verapamil (calan) (1 trial)
Trials (5 total)
Trial APIs (4 total)